Identification of Histone Modification Interaction Networks

组蛋白修饰相互作用网络的鉴定

基本信息

  • 批准号:
    7570472
  • 负责人:
  • 金额:
    $ 26.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-20 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Eukaryotic DNA is compacted through the formation of a nucleoprotein complex known as chromatin. The primary protein components of this complex are the core histones H2A, H2B, H3 and H4. The core histones form an octameric complex around which DNA wraps to form the nucleosome which is the basic repeating structure that serves as the foundation for higher order chromatin folding. As the packaging of DNA into chromatin places severe constraints on the accessibility of DNA, the ability to regulate chromatin structure is critical for cellular processes that require access to DNA such as transcription, DNA replication and DNA repair. The post-translational modification of the core histones has emerged as an important mechanism by which chromatin structure is modulated in cells. Accordingly, the core histones are the sites of numerous modifications. An intriguing aspect of histones modifications, which has emerged in the past few years, is that they do not function in isolation. There are now several examples of cross-talk between different modifications. For example, the ubiquitylation of histone H2B lysine 123 is required for the methylation of histone H3 lysines 4 and 79. Hence, modifications on one histone can influence the presence of other modifications. Our proposal is to combine yeast genetics, stable isotope labeling and mass spectrometry to comprehensively and quantitatively identify the network of interactions that exist between histone modifications. We will systematically mutate all sites of histone modification in the yeast core histones. We will then use stable isotope labeling and mass spectrometry to quantitate all of the histone modifications in the mutant strain relative to a wild type control. In this way, an unbiased picture will be obtained of all the cross-talk that exists between modifications in the core histones. PUBLIC HEALTH RELEVANCE: Due to its enormous linear length, the genomic DNA of eukaryotes needs to be highly condensed to fit inside cells. The DNA is condensed through packaging with proteins known as histones into a complex called chromatin. Cells must also be able to regulate the degree to which specific regions of DNA are condensed so that the DNA can become accessible when necessary. One important mechanism to regulate chromatin condensation is through modifications to the histone proteins. This proposal seeks to identify interactions that exist between different sites of histone modification. An understanding of how histone modifications function is important for human health as defects in the regulation of histone modifications and chromatin structure play critical roles in diseases such as cancer.
描述(由申请人提供): 真核DNA通过形成称为染色质的核蛋白复合物而被压缩。该复合物的主要蛋白质组分是核心组蛋白H2A、H2B、H3和H4。核心组蛋白形成八聚体复合物,DNA围绕该复合物缠绕以形成核小体,核小体是作为高级染色质折叠的基础的基本重复结构。由于DNA包装到染色质中严重限制了DNA的可及性,因此调节染色质结构的能力对于需要接近DNA的细胞过程(例如转录、DNA复制和DNA修复)至关重要。核心组蛋白的翻译后修饰已经成为细胞中染色质结构调节的重要机制。因此,核心组蛋白是许多修饰的位点。在过去几年中出现的组蛋白修饰的一个有趣的方面是,它们并不是孤立地起作用的。现在有几个不同修改之间串扰的例子。例如,组蛋白H3赖氨酸4和79的甲基化需要组蛋白H2B赖氨酸123的泛素化。因此,一个组蛋白上的修饰可以影响其他修饰的存在。我们的建议是结合联合收割机酵母遗传学,稳定同位素标记和质谱,全面和定量地确定组蛋白修饰之间存在的相互作用网络。我们将系统地突变酵母核心组蛋白中组蛋白修饰的所有位点。然后,我们将使用稳定同位素标记和质谱法来定量相对于野生型对照的突变株中的所有组蛋白修饰。通过这种方式,将获得核心组蛋白中修饰之间存在的所有串扰的无偏图像。公共卫生相关性:由于其巨大的线性长度,真核生物的基因组DNA需要高度浓缩以适应细胞内部。DNA通过与被称为组蛋白的蛋白质包装而浓缩成一种称为染色质的复合物。细胞还必须能够调节DNA特定区域的浓缩程度,以便在必要时可以访问DNA。调节染色质凝聚的一个重要机制是通过对组蛋白的修饰。该提案旨在确定组蛋白修饰的不同位点之间存在的相互作用。了解组蛋白修饰如何发挥作用对人类健康很重要,因为组蛋白修饰和染色质结构调节的缺陷在癌症等疾病中起着关键作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael A. Freitas其他文献

Determination of Relative Ordering of Activation Energies for Gas-Phase Ion Unimolecular Dissociation by Infrared Radiation for Gaseous Multiphoton Energy Transfer
通过红外辐射确定气态多光子能量转移的气相离子单分子解离活化能的相对有序度
  • DOI:
    10.1021/ja9925397
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Michael A. Freitas;and Christopher L. Hendrickson;A. Marshall
  • 通讯作者:
    A. Marshall
Identification of a DNA methylation point in the promoter region of the bovine CYP21 gene.
牛 CYP21 基因启动子区域 DNA 甲基化点的鉴定。
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0.4
  • 作者:
    A. M. D. Silva;Michael A. Freitas;Á. Rios;A. Renzi;R. Lôbo;M. A. V. Galerani;R. A. Vila;E. S. Ramos
  • 通讯作者:
    E. S. Ramos
Comparative Analysis Between Different Configurations in a Biomass Gasifier and a Genset for Electrical Energy Production
生物质气化炉和发电发电机组不同配置的比较分析
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. D. Silva;Francisco Everton Tavares de Luna;Vicente de Vasconcelos Claudino Filho;Michael A. Freitas
  • 通讯作者:
    Michael A. Freitas
Techniques for estimating genetically variable peptides and semi-continuous likelihoods from massively parallel sequencing data.
从大规模并行测序数据估计遗传可变肽和半连续可能性的技术。
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    August E. Woerner;Benjamin Crysup;F. C. Hewitt;Myles W. Gardner;Michael A. Freitas;B. Budowle
  • 通讯作者:
    B. Budowle
The applicability of fingernail lead and cadmium levels as subchronic exposure biomarkers for preschool children.
指甲铅和镉水平作为学龄前儿童亚慢性暴露生物标志物的适用性。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    A. S. Oliveira;E. C. Costa;E. C. Pereira;Michael A. Freitas;B. Freire;B. L. Batista;M. Luz;K. P. Olympio
  • 通讯作者:
    K. P. Olympio

Michael A. Freitas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael A. Freitas', 18)}}的其他基金

Acquisition of a Next Generation Orbitrap MS
获得下一代 Orbitrap MS
  • 批准号:
    8640367
  • 财政年份:
    2014
  • 资助金额:
    $ 26.25万
  • 项目类别:
Identification of Histone Modification Interaction Networks
组蛋白修饰相互作用网络的鉴定
  • 批准号:
    7897917
  • 财政年份:
    2009
  • 资助金额:
    $ 26.25万
  • 项目类别:
Acquisition of a high-throughput high mass accuracy MS for chromatin research
获取用于染色质研究的高通量高质量准确度 MS
  • 批准号:
    7215080
  • 财政年份:
    2007
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modification in Cancer
癌症组蛋白修饰的筛选试验
  • 批准号:
    6941103
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modification in Cancer
癌症组蛋白修饰的筛选试验
  • 批准号:
    7115333
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modification in Cancer
癌症组蛋白修饰的筛选试验
  • 批准号:
    6762146
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modifications in Cancer
癌症组蛋白修饰的筛选分析
  • 批准号:
    8069229
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modification in Cancer
癌症组蛋白修饰的筛选试验
  • 批准号:
    7256926
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modifications in Cancer
癌症组蛋白修饰的筛选分析
  • 批准号:
    8268528
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:
Assays for Screening Histone Modifications in Cancer
癌症组蛋白修饰的筛选分析
  • 批准号:
    8490699
  • 财政年份:
    2004
  • 资助金额:
    $ 26.25万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了